Skip to main content


Show all news items

Alliance Research Catalyst fund now open for applications


The Monash Warwick Alliance is delighted to announce the launch of the Alliance Research Catalyst fund. This is open to academic staff to support the development of new, strategically-aligned research initiatives, with high potential, that combine complementary aspects of each institution towards novel and sustainable outcomes.



Founded in 2012, the award-winning Alliance supports a diverse range of research and student-led projects. The Alliance Catalyst fund will replace the Alliance Seed Funding Scheme in response to feedback from a series of stakeholder engagement workshops held to inform the Alliance Research Strategy refresh. Historically the Alliance Seed Fund had been restricted to planning meetings, network building and workshop activities, now the Alliance Catalyst fund can also be used to fund pilot research studies/fieldwork where this is important to enable a subsequent funding application and/or engagement with external parties such as government. It is also possible to use this fund for visiting fellows to enable sharing, development and review of innovative research activity / policy developments through exchanges of leading academics. The visiting fellow may be a Warwick or Monash member of staff or a third party professional external to the Alliance who has made an impact or are a leading figure in their field.


The Alliance has a history of supporting new research initiatives. Last year a multidisciplinary group led by Amrik Sohal, Professor of Management in the Monash Business School and Jan Godsell, Professor of Operations and Supply Chain Strategy in WMG (Warwick Manufacturing Group), along with colleagues from the Monash Institute of Medical Engineering and the Warwick Business School, were awarded seed funding to apply operations and supply chain strategies and management techniques to the delivery of personalised medical technologies and pharmaceuticals.


“Traditional manufacturing in Australia and the UK has been in decline, but has residual capability essential to new types of manufacturing systems. The MWA funding provided an opportunity for us to identify these capabilities and their potential contribution to the growing trend towards more patient-centric medicines and pharmaceuticals,” says Professor Godsell.


“The workshops and focus group discussion sessions at WMG and Monash University brought together experts from industry (Medical Technologies and Pharmaceuticals), state government and academia, and have enabled the team to identify the key challenges and future research opportunities,” says Professor Sohal. “As a result the team is making a significant input into developing external grant applications for future research, including submission to the Australian Research Council’s Industrial Transformation Training Centres scheme.”

Thu 02 November 2017, 15:46

Talk to us...